News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Massachusetts Life Sciences Center And International Partners To Announce First Round Of Grants Under ICIP Program And Exciting News About The Future Of The International Program

3/7/2014 9:30:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

March 7th 2014 -- Contact: Angus G. McQuilken, MLSC Vice President for Communications and Marketing
Phone: 617-921-7749

What: The Massachusetts Life Sciences Center (MLSC) and four international partner regions on Monday, March 10th, will announce more than $1 million in the first round of grants under the MLSC’s International Collaborative Industry Program (ICIP) at a press conference at the Bio Europe Spring Convention in Turin, Italy. The Center and its partner regions will also make an important announcement about the future of the ICIP program.

The four regions that have partnered with Massachusetts in the first year of the program are Victoria, Australia (Department of State Development Business and Innovation (DSDBI); the Wallonia region of Belgium (BioWin); Quebec, Canada (CQDM); and Alsace in France (Alsace BioValley).
Who: The MLSC will be joined by international partners that are participating in the ICIP program and at least one of the companies that will be announced as being part of the first round of awardees. Speakers will include:
- Massachusetts Life Sciences Center President & CEO Susan Windham-Bannister, Ph.D.
- Frederic Druck, Communication & International Relations Director, BioWin (Wallonia)
- Agnès Legoll, Director Europe & International, Alsace BioValley

When: Monday, March 10th, 2014, 10 a.m. local time in Turin

Where: Bio Europe Spring, Oval Lingotto, Via Nizza n°294, Turin, Italy, EBD Booth (#24)

About the Massachusetts Life Sciences Center
The Massachusetts Life Sciences Center (MLSC) is an investment agency that supports life sciences innovation, research, development and commercialization. The MLSC is charged with implementing a 10-year, $1-billion, state-funded investment initiative. These investments create jobs and support advances that improve health and well-being. The MLSC offers the nation’s most comprehensive set of incentives and collaborative programs targeted to the life sciences ecosystem. These programs propel the growth that has made Massachusetts the global leader in life sciences. The MLSC creates new models for collaboration and partners with organizations, both public and private, around the world to promote innovation in the life sciences. For more information, visit

About the International Collaborative Industry Program (ICIP)
The MLSC’s International Collaborative Industry Program (ICIP) seeks to promote collaboration and idea exchange between life sciences companies around the world, as well as to stimulate the development of new products or processes intended for commercialization. ICIP accepts project proposals rooted in the life sciences: Biotechnology, pharmaceuticals, medical devices, diagnostics and bioinformatics. Projects sponsored together by a Massachusetts life sciences company and a company from one of the participating international partner regions are eligible to apply for joint funding from the MLSC and the respective international partner agency.

Help employers find you! Check out all the jobs and post your resume.

Read at

comments powered by Disqus